301 related articles for article (PubMed ID: 29284110)
61. Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.
Sakurada Y; Nakamura Y; Yoneyama S; Mabuchi F; Gotoh T; Tateno Y; Sugiyama A; Kubota T; Iijima H
Ophthalmic Res; 2015; 53(1):2-7. PubMed ID: 25472810
[TBL] [Abstract][Full Text] [Related]
62. Species differences in ocular pharmacokinetics and pharmacological activities of regorafenib and pazopanib eye-drops among rats, rabbits and monkeys.
Horita S; Watanabe M; Katagiri M; Nakamura H; Haniuda H; Nakazato T; Kagawa Y
Pharmacol Res Perspect; 2019 Dec; 7(6):e00545. PubMed ID: 31763044
[TBL] [Abstract][Full Text] [Related]
63. Effect of cediranib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, in a mouse model of choroidal neovascularization.
Kang S; Park KC; Yang KJ; Choi HS; Kim SH; Roh YJ
Clin Exp Ophthalmol; 2013; 41(1):63-72. PubMed ID: 22594647
[TBL] [Abstract][Full Text] [Related]
64. Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization.
Fu Y; Zhang Z; Webster KA; Paulus YM
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540673
[TBL] [Abstract][Full Text] [Related]
65. Intravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats.
Bae JH; Hwang AR; Kim CY; Yu HG; Koh HJ; Yang WI; Chang HR; Lee SC
PLoS One; 2017; 12(6):e0180482. PubMed ID: 28666022
[TBL] [Abstract][Full Text] [Related]
66. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
[TBL] [Abstract][Full Text] [Related]
67. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T
Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
[TBL] [Abstract][Full Text] [Related]
68. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase.
Matsui J; Funahashi Y; Uenaka T; Watanabe T; Tsuruoka A; Asada M
Clin Cancer Res; 2008 Sep; 14(17):5459-65. PubMed ID: 18765537
[TBL] [Abstract][Full Text] [Related]
69. JNK inhibition reduces apoptosis and neovascularization in a murine model of age-related macular degeneration.
Du H; Sun X; Guma M; Luo J; Ouyang H; Zhang X; Zeng J; Quach J; Nguyen DH; Shaw PX; Karin M; Zhang K
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2377-82. PubMed ID: 23341606
[TBL] [Abstract][Full Text] [Related]
70. Activator of G-protein signaling 8 is involved in VEGF-induced choroidal neovascularization.
Hayashi H; Mamun AA; Takeyama M; Yamamura A; Zako M; Yagasaki R; Nakahara T; Kamei M; Sato M
Sci Rep; 2019 Feb; 9(1):1560. PubMed ID: 30733465
[TBL] [Abstract][Full Text] [Related]
71. Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular Permeability.
Nagai N; Ju M; Izumi-Nagai K; Robbie SJ; Bainbridge JW; Gale DC; Pierre E; Krauss AH; Adamson P; Shima DT; Ng YS
Am J Pathol; 2015 Sep; 185(9):2534-49. PubMed ID: 26188133
[TBL] [Abstract][Full Text] [Related]
72. PKR promotes choroidal neovascularization via upregulating the PI3K/Akt signaling pathway in VEGF expression.
Zhu M; Liu X; Wang S; Miao J; Wu L; Yang X; Wang Y; Kang L; Li W; Cui C; Chen H; Sang A
Mol Vis; 2016; 22():1361-1374. PubMed ID: 27994435
[TBL] [Abstract][Full Text] [Related]
73. Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration.
Shin JY; Kwon KY; Byeon SH
Acta Ophthalmol; 2015 Sep; 93(6):524-32. PubMed ID: 25581639
[TBL] [Abstract][Full Text] [Related]
74. Amount of Mononuclear Phagocyte Infiltrate Does Not Predict Area of Experimental Choroidal Neovascularization (CNV).
Will-Orrego A; Qiu Y; Fassbender ES; Shen S; Aranda J; Kotagiri N; Maker M; Liao SM; Jaffee BD; Poor SH
J Ocul Pharmacol Ther; 2018 Sep; 34(7):489-499. PubMed ID: 30188257
[TBL] [Abstract][Full Text] [Related]
75. Safety of ranibizumab therapy in wet AMD and the role of vascular endothelial growth factors in physiological angiogenesis.
Figurska M; Robaszkiewicz J; Wierzbowska J
Klin Oczna; 2010; 112(4-6):147-50. PubMed ID: 20825071
[TBL] [Abstract][Full Text] [Related]
76. Shikonin alleviates choroidal neovascularization by inhibiting proangiogenic factor production from infiltrating macrophages.
Wang Y; Xie L; Zhu M; Guo Y; Tu Y; Zhou Y; Zeng J; Zhu L; Du S; Wang Z; Zhang Y; Liu X; Song E
Exp Eye Res; 2021 Dec; 213():108823. PubMed ID: 34752817
[TBL] [Abstract][Full Text] [Related]
77. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.
Kourlas H; Abrams P
Clin Ther; 2007 Sep; 29(9):1850-61. PubMed ID: 18035187
[TBL] [Abstract][Full Text] [Related]
78. Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy.
de Oliveira Dias JR; Rodrigues EB; Maia M; Magalhães O; Penha FM; Farah ME
Br J Ophthalmol; 2011 Dec; 95(12):1631-7. PubMed ID: 21546514
[TBL] [Abstract][Full Text] [Related]
79. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
80. Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy.
Rush RB; Rush SW; Aragon AV; Ysasaga JE
Am J Ophthalmol; 2014 Aug; 158(2):337-44. PubMed ID: 24844972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]